Post-earnings recap
Reported
Thu, Feb 12, 2026
EPS actual
$-0.13
EPS est.
$-0.19
EPS surprise
+30.11%
1-day move
-8.56%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report shows that while 10X Genomics Inc managed to beat EPS expectations, the stock fell by 8.56% in reaction. This decline may reflect investor concerns over the lack of revenue data and management's cautious tone regarding future market conditions. Without guidance, investors may be uncertain about the company's direction in the upcoming quarters.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | -$0.13 | N/A | +30.11% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about market conditions affecting growth. They are focusing on adapting their strategies to navigate these challenges.
Management highlighted ongoing challenges in the market.
They emphasized the need for strategic adjustments moving forward.